Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4104455 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL64957 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL9720673 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829291 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829172 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL830178 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829553 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL679835 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL98075 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL4092007 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331228-B2 | Photocurable resin composition, cured product, and laminated body | THREEBOND CO., LTD. (JP) | 2025-06-17 | — | — | US | claimed |
| US-11560475-B2 | Photocurable resin composition, cured product, and laminate | THREEBOND CO., LTD. (JP) | 2023-01-24 | — | — | US | claimed |
| US-9905855-B2 | Binder composition for non-aqueous secondary battery electrode | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2018-02-27 | — | — | US | claimed |
| EP-2121025-A2 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | Hananja Ehf (IS) | 2009-11-25 | — | — | EP | claimed |
| US-20090227568-A1 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2009-09-10 | — | — | US | claimed |
| US-20080275030-A1 | alkoxy-polyethylene glycol or (ethylene oxide)1-10 adduct of methanol, ethanol, propanol, isopropanol and cyclopropanol; benzodiazepine; midazolam as a liqid therapeutic agent; less irritation to mucosal membrane when administered through Mucosal; enhances solubility of drug | IKANO THERAPEUTICS, INC. (FORMERLY KNOWN AS "INTRANASAL THERAPEUTICS, INCORPORATED") | 2008-11-06 | — | — | US | claimed |
| WO-2008089426-A2 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2008-07-24 | — | — | WO | claimed |
| US-20260115361-A1 | METHOD FOR PRODUCING ANTITHROMBOGENIC MATERIAL | TOYOBO CO.,LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12595401-B2 | Adhesive set, adhesive body, and method for producing same | RESONAC CORPORATION (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4714983-A1 | PHOTOCURABLE RESIN COMPOSITION AND CURED OBJECT FORMED THEREFROM | ThreeBond Co., Ltd. (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4691508-A1 | METHOD FOR MANUFACTURING ANTITHROMBOTIC MEDICAL DEVICE | Toyobo Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12539313-B2 | Microbial removal | CAPRETTO EHF. (IS) | 2026-02-03 | — | — | US | disclosed |
| EP-3934753-B1 | MICROBIAL REMOVAL | CAPRETTO EHF (IS) | 2025-11-05 | — | — | EP | disclosed |
| US-20090227568-A1 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2009-09-10 | — | — | US | disclosed |
| US-20080275030-A1 | alkoxy-polyethylene glycol or (ethylene oxide)1-10 adduct of methanol, ethanol, propanol, isopropanol and cyclopropanol; benzodiazepine; midazolam as a liqid therapeutic agent; less irritation to mucosal membrane when administered through Mucosal; enhances solubility of drug | IKANO THERAPEUTICS, INC. (FORMERLY KNOWN AS "INTRANASAL THERAPEUTICS, INCORPORATED") | 2008-11-06 | — | — | US | disclosed |
| WO-2008089426-A2 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2008-07-24 | — | — | WO | disclosed |
| US-20060289833-A1 | Esters of phosphorus-oxygen acids, these esters comprising alkoxy groups, and their use as corrosion inhibitors and flameproofing agents | BASF ATKIENGESELLSCHAFT (DE) | 2006-12-28 | — | — | US | disclosed |
| US-6416931-B2 | WHEREIN LOWERING OF BRIGHTNESS IS SUPPRESSED IN A PLASMA DISPLAY PANEL | HITACHI CHEMICAL CO., LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| US-6329111-B1 | UNIFORM THICKNESS AND SHAPE ON THE WALL SURFACE OF A BARRIER RIB AND THE BOTTOM OF THE SPACE; SUBSTRATE HAS UNEVENNESS AND PHOSPHOR LAYER FORMED ON THE INNER SURFACE OF CONCAVE PORTION; FLAT PLATE MULTICOLOR PLASMA DISPLAY PANEL | HITACHI CHEMICAL COMPANY (JP) | 2001-12-11 | — | — | US | disclosed |
| US-4194066-A | POLYMERIZING POLYOXYALKYLENE GLYCOL (METH)ACRYLATES | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1980-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115361-A1 | METHOD FOR PRODUCING ANTITHROMBOGENIC MATERIAL | SERPINC1, FGB, ADAMTS13 | MEN1 490/4885KMT2A 1470/4885TSHR 149/4885 |
| US-20090227568-A1 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | TMEM205, NUP205, PIGS | MEN1 832/4885KMT2A 3911/4885TSHR 2833/4885 |
| US-12595401-B2 | Adhesive set, adhesive body, and method for producing same | EPCAM, LPO, SET | MEN1 1416/4885KMT2A 1832/4885TSHR 1117/4885 |
| US-12539313-B2 | Microbial removal | CUTA, MIF, PCNA | MEN1 782/4885KMT2A 2838/4885TSHR 811/4885 |
| US-20080275030-A1 | alkoxy-polyethylene glycol or (ethylene oxide)1-10 adduct of methanol, ethanol, propanol, isopropanol and cyclopropanol; benzodiazepine; midazolam as a liqid therapeutic agent; less irritation to mucosal membrane when administered through Mucosal; enhances solubility of drug | OPRD1, DRD2, DRD1 | MEN1 3906/4885KMT2A 2581/4885TSHR 2673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.